09966 ALPHAMAB-B
- 5.220
- +0.020+0.38%
ALPHAMAB-B News
ALPHAMAB-B: (1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: CHANGE IN SHAREHOLDING STRUCTURE OF CONTROLLING SHAREHOLDERS
ALPHAMAB-B: COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
ALPHAMAB-B: PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
ALPHAMAB-B: GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: GRANT OF SHARE OPTIONS
ALPHAMAB-B: ADOPTION OF THE POST-IPO SHARE OPTION SCHEME
ALPHAMAB-B: GREEN APPLICATION FORM
ALPHAMAB-B: YELLOW APPLICATION FORM
ALPHAMAB-B: WHITE APPLICATION FORM
ALPHAMAB-B: GLOBAL OFFERING
Analysis
Price Target
No Data
